SCHEMBL13638548

SCHEMBL13638548

C=C1CC(Nc2nccc(-c3c[nH]c4c(Br)cccc34)n2)CC(C)(C)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.48
DYRK1A Q13627 4/20 0.48
CDK5 Q00535 3/20 0.48
CLK1 P49759 2/20 0.48
CDK5R1 Q15078 2/20 0.48
RET P07949 8/20 0.45
CDK1 P06493 5/20 0.44
CCNB1 P14635 4/20 0.44
CCNB2 O95067 3/20 0.44
CCNB3 Q8WWL7 3/20 0.44
CDC7 O00311 3/20 0.44
JAK2 O60674 3/20 0.44
MAP4K4 O95819 3/20 0.44
PIM1 P11309 3/20 0.44
PRKACA P17612 3/20 0.44
FLT3 P36888 3/20 0.44
JAK3 P52333 3/20 0.44
PIM3 Q86V86 3/20 0.44
HIPK2 Q9H2X6 3/20 0.44
MKNK2 Q9HBH9 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638546 0.90 RET (0.46) GSK3BDYRK1ACDK5CLK1CDK5R1
SCHEMBL13638549 0.90 RET (0.46) GSK3BDYRK1ARETCDK1CCNB1
SCHEMBL13638597 0.89 RET (0.45) GSK3BDYRK1ACDK5CLK1CDK5R1
SCHEMBL13638444 0.89 DYRK1A (0.48) GSK3BDYRK1ACDK5RETCDK1
SCHEMBL13638328 0.89 RET (0.45) GSK3BDYRK1ACDK5RETCDK1
SCHEMBL13638443 0.88 GSK3B (0.52) GSK3BDYRK1ACDK5RETCDK1
SCHEMBL13638596 0.87 GSK3B (0.51) GSK3BDYRK1ACDK5RETCDK1
SCHEMBL3472286 0.87 GSK3B (0.54) GSK3BDYRK1ACDK5CLK1CDK5R1
SCHEMBL13638446 0.85 GSK3B (0.52) GSK3BDYRK1ACDK5CLK1CDK5R1
SCHEMBL13638594 0.85 MAPK8 (0.61) GSK3BDYRK1ACDK5CLK1CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed